Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications
Clinical trial NCT06299761 · TERMINATED
Trial details
- NCT number
- NCT06299761
- Sponsor
- Boundless Bio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-28
- Primary completion
- 2025-06-25
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.